NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis
Advanced SearchBrowse by AnalyteBrowse by Pre-analytical FactorSearch SOPsSOP Compendiums

Hemagglutinin inhibition (HAI) Assay   Add to my SOP compendium

BRD ID: 1,122

Source: HIMC Tier: SOP Number of times downloaded: 697

Description

This document describes the protocols used by the Human Immune Monitoring Center (HIMC) at Stanford School of Medicine for processing serum and determining hemagglutination using an HAI assay. It is a product of HIMC and is available at http://iti.stanford.edu/himc/protocols.html.

Documents for Download

HAI_Assay072612.pdf [Size: 386 KB]
Biospecimens
  • Fluid - Serum
Diagnoses
  • General
Topics
  • Biospecimen Processing
  • Platform-specific Methodology

Associated SOP Compendiums

News and Announcements

  • April 24, 2024: Biobanking for Precision Medicine Seminar
  • Most Popular SOPs in March 2024
  • New SOPs Available
    • More...